Back in business after a spell in limbo, Ironshore says it has raised $143M for ADHD drug rollout
It looks like Ironshore Pharmaceuticals is back in business.
Seven months after the company shuttered its commercial ops as its new drug application for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
